|Last Price$55.44||Day Change (%)-1.48%|
|Open Price$55.75||Day Change ($)-0.83|
|Day Range55.41–56.33||52-Week Range34.51–58.32|
As of Thu 12/05/2013 02:15 PM EST | USD
Forest Laboratories and Gedeon Richter Receive Complete Response Letter for Cariprazine
UPDATE: EBay, Amazon gain on Cyber Monday, J.C. Penney drops
Research and Markets: Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics - 2013
Welcome to the Forest Laboratories Second Quarter 2014 Earnings Conference Call. At this time, all participants have been placed in listen-only mode. The floor will be opened for your questions following the presentation.
Increased investor inflows and portfolio reshuffling (driven in part by a fairly valued market), has added breadth to the high-conviction and new-money purchases we've seen so far from our top managers.
Some great funds see attractive opportunities in the health-care sector.